Sriram Nadathur

Sriram Nadathur

Active Director Director DIN 00196449
DIN 00196449 First appointment Jun 2000 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 18 historical roles
Total affiliations 22 Since Jun 2000
Shareholding value Locked Premium profile
Directorship timeline
First appointment 16 Jun 2000
Active appointments 5
Total timeline records 22

Appointment history

Since 2000
Nadathur Estates Private Limited Director · 2022 - 2026
Current
Current
Nadathur Social Initiatives Llp Partner · 2016 - 2026
Current
Consilience Research Advisors Llp Designated Partner · 2016 - 2026
Current
Connexios Life Sciences Private Limited Director · 2003 - 2026
Current
Vida Trustees Private Limited Director · 2017 - 2021
Previous
Peony Technologies Llp Designated Partner · 2017 - 2025
Previous
Arkin Life Sciences Private Limited Director · 2012 - 2015
Previous
Kafnu Otis Bali Private Limited Director · 2010 - 2015
Previous
Samhita Social Ventures Private Limited Additional Director · 2010 - 2010
Previous
Achira Labs Private Limited Director · 2009 - 2014
Previous
Nitya Holdings Private Limited Director · 2009 - 2015
Previous
Abexome Biosciences Private Limited Director · 2007 - 2015
Previous
Tree Hill Estates Private Limited Director · 2007 - 2015
Previous
Nadathur Arts Private Limited Director · 2007 - 2015
Previous
Inexios Pharmaceuticals Private Limited Director · 2006 - 2015
Previous
Indegene Limited Director · 2005 - 2022
Previous
Previous
Metahelix Life Sciences Limited Nominee Director · 2005 - 2010
Previous
Shanthi Hospital And Research Centre Director · 2004 - 2015
Previous
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available